Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
48-Hour Action Plan: Patient Safety First Critical Reality Check First Your legal team's "6 months" likely refers to a full label revision, not initial safety signal reporting. FDA requires serious unexpected adverse events reported within 15 days (7 days if fatal).Read the full answer